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South Africa (SA) has the highest prevalence of 
HIV/AIDS of any country in the world, with 6.3 
million people living with HIV.[1] This high rate of 
infection adds complexity to a health system already 
overwhelmed by chronic kidney disease (CKD), 
particularly that caused by hypertension, diabetes and chronic 
glomerulonephritis.
Renal disease is common in HIV-infected individuals, affecting up 
to 30% of patients, and is associated with increased morbidity and 
mortality.[2-5] In SA, the spectrum of renal disease in HIV has been 
accumulating from renal biopsy data.[4,6] HIV-associated nephro-
pathy (HIVAN)[7,8] is the most common renal biopy finding and 
progresses rapidly to end-stage renal disease (ESRD) if the patient 
does not receive antiretroviral therapy (ART).[4] Other causes of renal 
disease in HIV-positive patients include tubulointerstitial nephritis 
from tuberculosis, drugs (tenofovir, rifampicin, sulfamethoxazole 
plus trimethoprim, amphotericin), and acute kidney injury due to 
sepsis.[9] The prevalence of ESRD is projected to increase further, as 
there is an emerging collision of epidemics of communicable and 
non-communicable diseases. HIV-positive patients are living longer 
on ART, with a rising incidence of the diseases of lifestyle including 
hypertension and diabetes.[10]
Black Africans, who are most affected by the HIV epidemic, 
also have a genetic predisposition to HIVAN. Epidemiological data 
confirm that African Americans in the USA are more prone to CKD 
than any other ethnic group.[11] The risk of ESRD has been reported 
to be three- to six-fold higher in African American than in Caucasian 
HIV-infected patients.[12] HIVAN represents a huge disease burden 
and is ranked as the third leading cause of ESRD among blacks aged 
20 - 64 years in the USA, lagging behind diabetes and hyperten -
sion.[13] Fortunately, ART has reduced the incidence of HIVAN and 
ESRD among African Americans[14] and black South Africans.[4] 
Until recently, the magnitude of CKD and the number of persons 
accessing renal replacement therapy in SA have been poorly 
documented. However, SA has taken positive steps to reinstate a 
functional renal registry, which confirms that currently 8.5% of 4 637 
chronic dialysis patients in the country are HIV-positive.[15] However, 
this number is underestimated owing to exclusion of a substantial 
number of HIV-positive patients from state sector dialysis units, 
because state hospitals require their patients to be transplantable 
in order to gain access to chronic dialysis. Given the risk of post-
transplant comorbidities, it is mandatory for HIV-positive patients to 
have a CD4 count >200 cells/µL, to have a suppressed viral load, and 
to have been stable on ART for 6 months in order to be considered for 
most state sector chronic dialysis.[16] Patients who do not fulfil these 
criteria are excluded from most state units.
Prior to availability of ART, HIV was a death sentence for 
individuals with CKD. Several studies suggested that survival rates 
were dismal, and owing to the poor prognosis, chronic renal 
replacement therapy (RRT) was rarely offered to patients.[17] This 
was particularly true in SA. Since introduction of ART, the overall 
survival of HIV-positive patients has increased dramatically. SA, 
which has the largest HIV treatment programme in the world and 
average treatment initiation rates of 30 000 per month,[1] now has a 
parallel need for increased access to RRT.
Since ART roll-out there has been growing evidence of little 
difference in survival between HIV-infected patients who are 
receiving efficacious ART compared with the general population 
on dialysis.[17] After comparing survival between 5 299 patients who 
received haemodialysis and 716 who received peritoneal dialysis (PD), 
the United States Renal Data System has also reported that dialysis 
modality is not a factor in survival of patients with HIVAN (hazard 
ratio: peritoneal dialysis v. haemodialysis 1.04, 95% confidence interval 
(CI) 0.96 - 1.13).[18] However, the study was limited by the lack of 
information regarding CD4 counts and viral loads. In the pre-ART 
era, the proportion of patients with peritonitis in the HIV-infected 
population treated with PD was not different from that of the HIV-
negative population treated with PD.[19] Gorrin et al.[20] demonstrated 
an increase in overall survival and a decrease in PD-associated 
complications compared with previous studies. In this small study 
of eight HIV-positive patients, cardiovascular events were the main 
cause of death (two patients, 25%). However, until large studies 
are conducted, controlling for stage of HIV infection and other 
comorbidities, selecting dialysis modality for HIV-infected patients 
should be similar to other patients with ESRD.
Although the evidence is encouraging regarding RRT in HIV-
positive patients, the Dialysis Outcomes and Practice Patterns 
Study (DOPPS)[21] concluded that HIV-positive patients are at 
increased risk on haemodialysis. This study pooled data among 
haemo dialysis patients in Europe, Japan and the USA and confirmed 
a nearly three-fold greater mortality risk on haemodialysis among 
individuals with HIV infection (relative risk (RR) 2.96; p<0.0001), 
with most deaths during the first year of dialysis (RR 5.60; 
p<0.01), but once again did not distinguish between those currently 
receiving or not receiving ART.[21]
It is well documented that transplantation is the best treatment 
option for CKD in patients without HIV. In spite of the cost of 
the operation and of immunosuppressive medication, it is also the 
most cost-effective treatment option. Given the high haemodialysis 
mortality seen in the DOPPS, should we not be striving for dialysis 
to be the bridge to transplantation in HIV-positive patients? Being 
HIV-positive was previously an absolute contraindication to renal 
transplantation. With the advent of ART, renal transplantation using 
HIV-negative donor kidneys in positive recipients has been employed 
successfully for HIV-infected patients with ESRD.[22] 
In a prospective study by Mysore et al.[23] (presented at the 
American Transplant Congress 2008) long-term survival was 
described in 132 HIV-positive patients with ESRD listed for kidney 
transplantation during February 2001 and December 2006. Half 
the cohort (65 patients) received kidney transplants and the other 
half (67 patients) remained on dialysis while waiting for kidney 
donation. The selection criteria for waiting list placement included 
maintenance on ART with a suppressed viral load and an absolute 
CD4 count of 200 cells/µL. The primary endpoint was patient 
death. Patient survival in the transplant v. the dialysis group at 1 
year was 91% v. 89% (p=0.9) and at 5 years 80% v. 26% (p=0.000). 
Despite equal therapeutic suppression of HIV infection with ART 
and similar comorbid factors, kidney transplantation significantly 
prolonged 5-year patient survival in HIV-positive patients compared 
with dialysis in this study.
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In SA, places on state dialysis programmes are severely restricted. There 
are additional problems of long waiting lists for transplantation and 
limited consent to organ donation. HIV-infected patients, like many 
others with comorbidity, are often denied treatment, while kidneys 
from HIV-infected deceased donors are discarded.[24] Transplantation 
of kidneys from HIV-positive donors to positive recipients has been 
pioneered at Groote Schuur Hospital, Cape Town, SA, significantly 
increasing the pool of donor kidneys to the advantage of both 
HIV-positive and HIV-negative patients.[25] To date, 29 HIV-positive 
individuals have been transplanted with kidneys from HIV-infected 
cadaver donors.  Preliminary data are extremely promising:  1-year 
patient survival is 86.36% and 3-year survival 72.73%, and graft survival 
is 90.91% at 1 year and 80.81% at 3 years.[26] Transplanting HIV-
infected patients with kidneys from HIV-positive donors represents a 
significant advance in our resource-constrained environment.
In this issue of the SAMJ, Fabian et al.[27] demonstrate that 
haemodialysis in black African HIV-positive patients in the private 
sector in SA imparts excellent overall survival in spite of higher hospital 
admission rates and higher morbidity from infection (particularly 
vascular access-related infections) compared with HIV-negative 
patients. This study contributes to the growing data reflecting good 
outcomes for HIV-positive patients on dialysis. However, in Fabian’s 
cohort a high proportion of patients had unexplained suboptimal viral 
suppression rates that would disqualify them as transplant recipients. 
In resource-restricted settings such as SA, attention needs to be geared 
towards prevention of CKD and slowing progression towards ESRD. 
HIV contributes to a high risk of CKD, and as such HIV-positive patients 
should be screened for CKD at their first encounter with any health 
service. This is particularly important in view of the fact that HIVAN can 
occur with high CD4 counts.[4] Screening should include urinalysis and 
measuring kidney function. Strategies should include fast-tracking for 
ART for patients manifesting renal involvement, awareness of tenofovir 
and sulfamethoxazole-trimethoprim toxicity, avoidance of nephrotoxic 
agents such as non-steroidal anti-inflammatory drugs, adequate fluid 
resuscitation when necessary, and efficient treatment of sepsis.[9]
Patients are living longer on ART and as such are at increased risk 
of developing hypertension and diabetes.[10] Diseases of lifestyle may 
emerge as a new epidemic in the HIV-positive population. Those who 
provide healthcare to HIV-positive patients need to be aware of the 
special renal issues relevant to HIV, and the potential for evolution to 
ESRD, and should work actively with HIV and nephrology specialists 
to improve the outcome and quality of life of patients.
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